© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Venous Thromboembolism
DOACs in Obese Patients Show Similar VTE Recurrence Rates to Non-Obese Patients
August 07, 2020
Article
The study paves the way for prospective multi-institutional randomized control trials to further re-enforce the safe use of direct oral anticoagulants in patients with obesity.
How VTE Screening Can Be Improved
July 31, 2020
Video
A discussion on how thromboembolism research and care could benefit from progression in diagnostics.
New Data Expands the Risk Pool for Mortality From Elevated Pulmonary Artery Pressure
July 30, 2020
Article
Patients with a mPAP of at least 19 mm Hg and pulmonary artery wedge pressure of 15 mm Hg or less had an adjusted hazard ratio for mortality of 1.71.
VTE May Not Be Significant Driver of Death
July 30, 2020
Article
A new systematic review and meta-analysis challenges the notion that preventing VTE is associated reduced mortality risk.
Inferior Vena Cava Filter Reduces DVT-Cancer Patient Risk of Pulmonary Embolism
July 24, 2020
Article
New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.
Improving VTE Research: Where to Start?
July 22, 2020
Video
An expert explains why little progress has been made in disease prevalence and burden in the US.
Apixaban Effective for Thromboprophylaxis After Surgery for Gynecologic Cancer
June 28, 2020
Article
A new randomized trial suggests oral apixaban may be as effective as enoxaparin for thromboprophylaxis following surgery for gynecologic cancer.
Gestational Hypertension Increases Risk of CVD, CHD But Not Thromboembolism
June 25, 2020
Article
A new systematic review and meta-analysis is shedding light on the impact gestational hypertension can have on future risk of cardiovascular diseases.
Post-Discharge Rivaroxaban Cuts Thromboembolic Events in Acutely Ill Patients
June 24, 2020
Article
An analysis of the MARINER trial is diving deeper into the impact of post-discharge prophylaxis with rivaroxaban in patients with more severe renal impairment.